AIKI   $3.57  1.98% Market Closed

AIkido Pharma Inc
Last Events:

2022-12-22 Signal in Stochastic changed from bearish weakening to bearish. The stochastic indicator is in the oversold territory and it heading north. These factors indicate that perhaps the downside trend is coming to an end. Last signal: entry into the oversold zone.

2022-12-22 Signal in Stochastic changed from bearish to bearish weakening. The stochastic indicator is in the oversold territory and it heading north. These factors indicate that perhaps the downside trend is coming to an end. Last signal: main and signal line crossing.

2022-12-21 Trend pattern changed from сужающийся канал to нисходящий клин.

2022-12-21 Trend pattern changed from нисходящий клин to сужающийся канал.

2022-12-21 Signal in RSI changed from bearish recovery to bullish reversal. RSI indicator is in the lower part of the neutral territory and left the oversold territory. These factors indicate that perhaps the downside trend is coming to an end price will probably head north Last signal: exit from the overbought zone.

2022-12-19 Signal in Stochastic changed from bullish weakening to bearish. The stochastic indicator is in the lower part of the neutral territory and it falls. These factors indicate that negative dynamics persists. Last signal: down-crossing the middle level.

2022-12-18 Signal in Stochastic changed from bearish to bullish weakening. The stochastic indicator is in the upper part of the neutral territory and it heading south. These factors indicate that the downside trend is forming. Last signal: main and signal line crossing.

2022-12-17 Signal in Stochastic changed from bullish weakening to bearish. The stochastic indicator is in the lower part of the neutral territory and it heading south. These factors indicate that negative dynamics is recovering. Last signal: main and signal line crossing.


Current temperature: 2.70
ST: 0, Cor:

50-50 Year Forecast
Low with 50% probability: 3.25
Target: 16.00
High with 49% probability: 6.84
Analyst Recommendations:
Number of estimates 1
Target Price Mean 16.00
Mean unverified/preliminary 16.00 / 16.00
Target Price Low / High 16.00 / 16.00
Median / STD DEV 16.00 / 0.00
Tech Forecasts:
More signals
  < 1M 1-3M > 3M
total Sell Sell Sell
rsi Sell Sell -
macd Sell Sell -
stoch Sell Sell Sell
ma20 Sell - -
ma50 Sell - -
ma100 - Sell -
Candlestick PatternDec. 20, 2022 Bullish Harami - consists of an unusually large black body followed by a small white body contained within large black body. It is considered as a bullish pattern when preceded by a downtrend.
ISIN US0088751062
ceo Mr. Anthony C. Hayes Esq.
Website https://www.aikidopharma.com
AIkido Pharma Inc., a biotechnology company, focuses on developing small-molecule anti-cancer therapeutics. The company's pipeline of therapeutics includes therapies for prostate cancer, pancreatic cancer, acute myeloid leukemia (AML), and acute lymphoblastic leukemia. It is developing DHA-dFdC, a pancreatic drug candidate; and KPC34, a small molecule treatment for acute myeloid leukemia and acute lymphoblastic leukemia. The company is also developing an antiviral platform that inhibits replication of viruses, including influenza virus, Ebolavirus and Marburg virus, SARS-CoV, MERS-CoV, and SARS-CoV-2. It has license agreements with the University of Texas, University of Maryland Baltimore, Silo Pharma Inc., and Wake Forest University Health Sciences. The company was formerly known as Spherix Incorporated and changed its name to AIkido Pharma Inc. in March 2021. AIkido Pharma Inc. was founded in 1967 and is headquartered in New York, New York.